Methods and compositions for the treatment of diseases of the eye
CA 2427334 C · Owner: Friedlander, Martin · Inventors: Bender, Hans-Markus; Lang, Ulrich; Friedlander, Martin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors .alpha.v.beta.3 and /or .alpha.v.beta.5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 30, 2001 and granted June 11, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 30, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 30, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.